About
Technology
Issues
FAQ
Links
Official Page
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
